Harel Insurance Investments & Financial Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-888
| Closed | -$15K | – | 548 |
|
|
2024
Q2 | $15K | Sell |
888
-175
| -16% | -$2.96K | ﹤0.01% | 458 |
|
|
2024
Q1 | $17K | Sell |
1,063
-303
| -22% | -$4.85K | ﹤0.01% | 455 |
|
|
2023
Q4 | $20K | Sell |
1,366
-232
| -15% | -$3.4K | ﹤0.01% | 496 |
|
|
2023
Q3 | $26K | Buy |
1,598
+768
| +93% | +$12.5K | ﹤0.01% | 526 |
|
|
2023
Q2 | $34K | Sell |
830
-640
| -44% | -$26.2K | ﹤0.01% | 524 |
|
|
2023
Q1 | $88K | Buy |
1,470
+650
| +79% | +$38.9K | ﹤0.01% | 417 |
|
|
2022
Q4 | $60K | Sell |
820
-120
| -13% | -$8.78K | ﹤0.01% | 449 |
|
|
2022
Q3 | $72K | Sell |
940
-67
| -7% | -$5.13K | ﹤0.01% | 455 |
|
|
2022
Q2 | $70K | Sell |
1,007
-486
| -33% | -$33.8K | ﹤0.01% | 455 |
|
|
2022
Q1 | $124K | Sell |
1,493
-562
| -27% | -$46.7K | ﹤0.01% | 429 |
|
|
2021
Q4 | $164K | Buy |
+2,055
| New | +$164K | ﹤0.01% | 440 |
|
|
2020
Q3 | – | Sell |
-2,000
| Closed | -$119K | – | 683 |
|
|
2020
Q2 | $119K | Buy |
+2,000
| New | +$119K | ﹤0.01% | 304 |
|